​

uniQure (QURE) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

QURE Stock Forecast

uniQure (QURE) stock forecast, based on 35 Wall Street analysts, predicts a 12-month average price target of $71.17, with a high of $110.00 and a low of $35.00. This represents a 4.79% increase from the last price of $67.92.

- $30 $60 $90 $120 $150 High: $110 Avg: $71.17 Low: $35 Last Closed Price: $67.92

QURE Stock Rating

uniQure stock's rating consensus is Buy, based on 35 Wall Street analysts. The breakdown includes 1 Strong Buy (2.86%), 31 Buy (88.57%), 3 Hold (8.57%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 35 3 31 1 Strong Sell Sell Hold Buy Strong Buy

QURE Price Target Upside V Benchmarks

TypeNameUpside
StockuniQure4.79%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts268
Avg Price Target$95.00$71.17$60.13
Last Closing Price$67.92$67.92$67.92
Upside/Downside39.87%4.79%-11.47%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 252101--13
Sep, 25291--12
Aug, 25292--13
Jul, 25292--13
Jun, 25292--13
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 06, 2025H.C. Wainwright$110.00$54.92100.29%61.96%
Oct 02, 2025Wells Fargo$80.00$54.9945.48%17.79%
Sep 25, 2025UBS$95.00$52.6580.44%39.87%
Sep 25, 2025Uy EarMizuho Securities$60.00$48.0924.77%-11.66%
Jul 30, 2025Cantor Fitzgerald$47.00$14.46225.03%-30.80%
Jul 29, 2025Chardan Capital$35.00$13.68155.85%-48.47%
Feb 28, 2025Wells Fargo$30.00$13.15128.14%-55.83%
Jan 07, 2025Luca IssiRBC Capital$24.00$17.6436.05%-64.66%
Nov 23, 2022Goldman Sachs$57.00$25.38124.59%-16.08%
Aug 08, 2022Matthew BarcusChardan Capital$60.00$18.64221.89%-11.66%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 06, 2025H.C. WainwrightNeutralNeutralhold
Sep 25, 2025Cantor FitzgeraldOverweightOverweighthold
Sep 25, 2025GuggenheimBuyBuyhold
Sep 25, 2025Wells FargoOverweightOverweighthold
Sep 24, 2025RBC CapitalOutperformOutperformhold
Sep 24, 2025H.C. WainwrightBuyBuyhold
Jan 07, 2025RBC CapitalOutperformOutperformhold
Jul 09, 2024GuggenheimBuyBuyhold
Mar 04, 2024Cowen & Co.NeutralNeutralhold
Jun 22, 2023Chardan CapitalBuyBuyhold

Financial Forecast

EPS Forecast

$-15 $-8 $-1 $6 $13 $20 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.81$7.17$-2.71$-6.47$-4.92----
Avg Forecast$-3.65$6.17$-3.75$-6.31$-4.08$-3.38$-2.65$0.24$1.59
High Forecast$-0.48$19.18$-0.76$-5.52$-2.60$-2.04$-1.18$0.94$4.29
Low Forecast$-11.33$0.81$-12.82$-6.79$-4.81$-4.08$-3.47$-1.77$0.02
Surprise %-23.01%16.21%-27.73%2.54%20.59%----

Revenue Forecast

$0 $300M $600M $900M $1B $2B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$37.51M$524.00M$106.48M$15.84M$27.12M----
Avg Forecast$116.44M$475.82M$30.57M$20.88M$41.03M$35.04M$115.19M$224.16M$426.50M
High Forecast$305.28M$1.25B$87.54M$24.70M$87.71M$80.89M$265.96M$230.88M$984.69M
Low Forecast$38.57M$157.60M$11.85M$17.22M$16.50M$8.45M$27.78M$217.44M$102.84M
Surprise %-67.78%10.13%248.31%-24.11%-33.91%----

Net Income Forecast

$-550M $-360M $-170M $20M $210M $400M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-125.02M$329.59M$-126.79M$-308.48M$-239.56M----
Avg Forecast$-173.76M$278.41M$-158.89M$-308.48M$-176.70M$-157.36M$-121.56M$-54.56M$75.77M
High Forecast$-22.69M$386.84M$-120.98M$-234.86M$-124.03M$-97.07M$-56.14M$44.92M$204.69M
Low Forecast$-540.09M$169.98M$-196.81M$-382.09M$-229.37M$-194.66M$-165.31M$-84.60M$1.02M
Surprise %-28.05%18.38%-20.20%-35.57%----

QURE Forecast FAQ

Is uniQure stock a buy?

uniQure stock has a consensus rating of Buy, based on 35 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 31 Buy, 3 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that uniQure is a favorable investment for most analysts.

What is uniQure's price target?

uniQure's price target, set by 35 Wall Street analysts, averages $71.17 over the next 12 months. The price target range spans from $35 at the low end to $110 at the high end, suggesting a potential 4.79% change from the previous closing price of $67.92.

How does uniQure stock forecast compare to its benchmarks?

uniQure's stock forecast shows a 4.79% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for uniQure over the past three months?

  • October 2025: 15.38% Strong Buy, 76.92% Buy, 7.69% Hold, 0% Sell, 0% Strong Sell.
  • September 2025: 16.67% Strong Buy, 75.00% Buy, 8.33% Hold, 0% Sell, 0% Strong Sell.
  • August 2025: 15.38% Strong Buy, 69.23% Buy, 15.38% Hold, 0% Sell, 0% Strong Sell.

What is uniQure’s EPS forecast?

uniQure's average annual EPS forecast for its fiscal year ending in December 2025 is $-3.38, marking a -31.30% decrease from the reported $-4.92 in 2024. Estimates for the following years are $-2.65 in 2026, $0.24 in 2027, and $1.59 in 2028.

What is uniQure’s revenue forecast?

uniQure's average annual revenue forecast for its fiscal year ending in December 2025 is $35.04M, reflecting a 29.19% increase from the reported $27.12M in 2024. The forecast for 2026 is $115.19M, followed by $224.16M for 2027, and $426.5M for 2028.

What is uniQure’s net income forecast?

uniQure's net income forecast for the fiscal year ending in December 2025 stands at $-157M, representing a -34.31% decrease from the reported $-240M in 2024. Projections indicate $-122M in 2026, $-54.563M in 2027, and $75.77M in 2028.